127 related articles for article (PubMed ID: 35940433)
1. Identification of a novel interplaying loop of PPARγ and respective lncRNAs are involved in colorectal cancer progress.
Hajipour M; Mokhtari K; Mahdevar M; Esmaeili M; Peymani M; Nasr-Esfahani MH; Mirzaei S; Hasehmi M; Hushmandi K; Ghaedi K
Int J Biol Macromol; 2022 Oct; 219():779-787. PubMed ID: 35940433
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA Expression Signatures of Colon Cancer Based on the ceRNA Network and Their Prognostic Value.
Cheng Y; Geng L; Wang K; Sun J; Xu W; Gong S; Zhu Y
Dis Markers; 2019; 2019():7636757. PubMed ID: 30984308
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing.
Li M; Guo D; Chen X; Lu X; Huang X; Wu Y
BMC Cancer; 2022 Jul; 22(1):780. PubMed ID: 35842644
[TBL] [Abstract][Full Text] [Related]
5. Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs.
Abd-Rabou AA; Abdelaziz AM; Shaker OG; Ayeldeen G
Mol Biol Rep; 2021 Oct; 48(10):6805-6820. PubMed ID: 34468912
[TBL] [Abstract][Full Text] [Related]
6. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of lncRNAs SNHG6, TRPM2-AS1, MIR4435-2HG, and hypomethylation of TRPM2-AS1 promoter in colorectal cancer.
Ghasemi T; Khalaj-Kondori M; Hosseinpour Feizi MA; Asadi P
Cell Biol Int; 2021 Dec; 45(12):2464-2478. PubMed ID: 34431156
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Allred CD; Kilgore MW
Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells.
Lee CJ; Han JS; Seo CY; Park TH; Kwon HC; Jeong JS; Kim IH; Yun J; Bae YS; Kwak JY; Park JI
Apoptosis; 2006 Mar; 11(3):401-11. PubMed ID: 16520894
[TBL] [Abstract][Full Text] [Related]
12. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
14. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
15. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
[TBL] [Abstract][Full Text] [Related]
16. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis.
Zhang H; Wang Z; Wu J; Ma R; Feng J
Cancer Med; 2019 Mar; 8(3):863-873. PubMed ID: 30714675
[TBL] [Abstract][Full Text] [Related]
18. KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines.
Rageul J; Mottier S; Jarry A; Shah Y; Théoleyre S; Masson D; Gonzalez FJ; Laboisse CL; Denis MG
Int J Cancer; 2009 Dec; 125(12):2802-9. PubMed ID: 19551868
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
20. Tissue-Specific Down-Regulation of the Long Non-Coding RNAs PCAT18 and LINC01133 in Gastric Cancer Development.
Foroughi K; Amini M; Atashi A; Mahmoodzadeh H; Hamann U; Manoochehri M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
